ArticleJournal of the American Academy of Dermatology2021
Incidence of severe COVID-19 outcomes in psoriatic patients treated with systemic therapies during the pandemic: A Biobadaderm cohort analysis.
Abstract readLetter
In one paragraph
Article in Journal of the American Academy of Dermatology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 5 of them syntheses that pooled it.
0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 5 pooled it
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 5 syntheses or guidelines pooled it.
- A systematic review and meta-analysis of investigating the mutual impact of COVID-19 and psoriasis: Focusing on COVID-19 course in psoriasis and the opinion on biologics in this setting.Immunity, inflammation and disease · 2023Pooled it
- Dupilumab therapy in atopic dermatitis is safe during COVID-19 infection era: A systematic review and meta-analysis of 1611 patients.Dermatologic therapy · 2022Pooled it
- SARS-CoV-2 (COVID-19) vaccination in dermatology patients on immunomodulatory and biologic agents: Recommendations from the Australasian Medical Dermatology Group.The Australasian journal of dermatology · 2021Guideline
- National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments.Journal of the American Academy of Dermatology · 2021Guideline
- Associations between COVID-19 and skin conditions identified through epidemiology and genomic studies.The Journal of allergy and clinical immunology · 2021Pooled it
- COVID-19 susceptibility, severity, and vaccine effectiveness in patients with psoriasis: a nationwide cohort study in South Korea.Scientific reports · 2025Article
- Management of Psoriasis Patients with Serious Infectious Diseases.Advances in therapy · 2024Review
- Inflammation Causes Exacerbation of COVID-19: How about Skin Inflammation?International journal of molecular sciences · 2022Review
- Assessing the Risk and Outcome of COVID-19 in Patients with Psoriasis or Psoriatic Arthritis on Biologic Treatment: A Critical Appraisal of the Quality of the Published Evidence.The Journal of investigative dermatology · 2022Article
- Psoriasis-related treatment exposure and hospitalization or in-hospital mortality due to COVID-19 during the first and second wave of the pandemic: cohort study of 1 326 312 patients in France.The British journal of dermatology · 2022Article
- Updates in Psoriasis Management: Based on selected presentations from Maui Derm 2021 on January 25-29 in Grand Wailea, Maui, Hawaii.The Journal of clinical and aesthetic dermatology · 2021Article
- Tumor necrosis factor inhibitors are associated with a decreased risk of COVID-19-associated hospitalization in patients with psoriasis-A population-based cohort study.Dermatologic therapy · 2021Article
- Biologics for Psoriasis during the COVID-19 Pandemic.Journal of clinical medicine · 2021Review
- Biologics for Psoriasis During the COVID-19 Pandemic.Frontiers in medicine · 2021Review
- The Risk of COVID-19 Pandemic in Patients with Moderate to Severe Plaque Psoriasis Receiving Systemic Treatments.Vaccines · 2020Review
- Biologics and Biosimilars in Psoriasis.Indian journal of dermatologyArticle
- Clinical Dermatology and COVID-19 Pandemic: Narrative Review.Indian journal of dermatologyArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Ofelia Baniandrés-RodríguezDepartment of Dermatology, CEIMI, Hospital General Universitario Gregorio Marañón, Madrid, Spain. Electronic address: ofelia.baniandres@salud.madrid.org.
Jaime Vilar-AlejoDepartment of Dermatology, Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain.
Raquel RiveraDepartment of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
José Manuel CarrascosaDepartment of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, Spain.
Esteban DaudénDepartment of Dermatology. Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP), Madrid, Spain.
Enrique Herrera-AcostaDepartment of Dermatology, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
Antonio Sahuquillo-TorralbaDepartment of Dermatology, Hospital Universitario y Politécnico La Fe; Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain. Facultad de Medicina, Universidad de Valencia, Spain.
Fran J Gómez-GarcíaDepartment of Dermatology, Hospital Universitario Reina Sofía, Cordoba, Spain.
Lula María Nieto-BenitoDepartment of Dermatology, CEIMI, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Pablo de la CuevaDepartment of Dermatology, Hospital Universitario Infanta Leonor, Madrid, Spain.
José Luis López-EstebaranzDepartment of Dermatology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
Isabel BelinchónDepartment of Dermatology, Hospital General Universitario de Alicante-ISABIAL, Alicante, Spain.
Marta Ferrán FarrésDepartment of Dermatology, Hospital del Mar, Parc de Salut Mar, Barcelona, Spain.
Mercè AlsinaDepartment of Dermatology, Hospital Clínic de Barcelona, UB, Barcelona Spain.
Lourdes Rodríguez Fernández-FreireDepartment of Dermatology. Hospital Virgen del Rocío, Sevilla, Spain.
Gregorio CarreteroDepartment of Dermatology, Hospital Universitario de Gran Canaria Dr Negrín, Las Palmas de Gran Canaria, Spain.
Carmen García-DonosoDepartment of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain.
Ferrán BallescáDepartment of Dermatology, Hospital Universitari Germans Trias i Pujol, Badalona, Universidad Autónoma de Barcelona, Barcelona, Spain.
Mar Llamas-VelascoDepartment of Dermatology. Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria de La Princesa (IIS-IP), Madrid, Spain.
Enrique Herrera-CeballosDepartment of Dermatology, Hospital Universitario Virgen de la Victoria, Málaga, Spain.
Rafael Botella-EstradaDepartment of Dermatology, Hospital Universitario y Politécnico La Fe; Instituto de Investigación Sanitaria La Fe (IIS La Fe), Valencia, Spain. Facultad de Medicina, Universidad de Valencia, Spain.
Diana Patricia Ruiz-GenaoDepartment of Dermatology, Hospital Universitario Fundación Alcorcón, Madrid, Spain.
Josep Riera-MonroigDepartment of Dermatology, Hospital Clínic de Barcelona, UB, Barcelona Spain.
Miguel Ángel Descalzo GallegoResearch Unit. Fundación Piel Sana AEDV, Madrid, Spain.
Ignacio García-DovalResearch Unit. Fundación Piel Sana AEDV, Madrid, Spain; Department of Dermatology, Complexo Hospitalario Universitario de Vigo, Vigo, Spain.
BIOBADADERM Study Group
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
AdultAgedCohort StudiesCOVID-19FemaleHumansIncidenceMaleMiddle AgedPsoriasisRegistriesSeverity of Illness IndexSpain
Identifiers
What OpenQuestion holds
Textmetadata
Read underepoch 390
Registered trials
None linked
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.